Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________________________ OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ________ Commission File Number 001-37687 _______________________________ EDITAS MEDICINE, INC. (Exact name of registrant as specified in its charter) _______________________________ FORM 10-Q _______________________________ (Mark One) ☐ QUARTERLY R ...